Nautilus Biotechnology (NAUT) Change in Acquisitions & Divestments (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $25.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 3.1% year-over-year to $25.8 million; the trailing twelve-month figure through Mar 2026 stood at $108.2 million (down 31.99% YoY), and the FY2025 full-year result was $109.0 million, down 29.87% from the prior year.
• Change in Acquisitions & Divestments retreated to $25.8 million in Q1 2026, from $34.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $67.0 million in Q2 2022 to a low of $14.2 million in Q1 2023.
• A 5-year average of $30.9 million and a median of $26.6 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 318.75% in 2022 and sank 73.13% in 2023, its largest moves.
• Tracing NAUT's Change in Acquisitions & Divestments over 5 years: stood at $21.1 million in 2022, then declined by 3.55% to $20.3 million in 2023, then surged by 219.41% to $65.0 million in 2024, then sank by 46.54% to $34.8 million in 2025, then decreased by 25.74% to $25.8 million in 2026.
• Business Quant data shows NAUT's Change in Acquisitions & Divestments at $25.8 million in Q1 2026, $34.8 million in Q4 2025, and $28.4 million in Q3 2025.